NeuroSense to strengthen PrimeC Canadian ALS submission with new NFL data

NRSN•2026-11-02

NeuroSense Therapeutics said it will strengthen its Canadian submission for PrimeC with new NFL data and is advancing discussions with commercialization partners for Canada.

1. Canadian submission

NeuroSense Therapeutics said it will strengthen its Canadian ALS submission for PrimeC with new NFL data. The company also said it is advancing discussions with commercialization partners for Canada.

NeuroSense to strengthen PrimeC Canadian ALS submission with new NFL data

1. Canadian submission

Related News

Papa John's International: UBS cuts target price to $21 from $28

ECB flags AI valuations, bond stress and fund losses as main risks

Lån og Spar expects ECB to raise rates again in December

Ingersoll Rand expands life sciences solutions with IVEK acquisition

Tower Semiconductor forecasts Q4 revenue of $600 million, plus or minus 5%